All Stories

  1. Re-engineering the disordered mind: clinical experimentation, dynamical systems, and AI for personalized psychiatry
  2. Pharmacological strategies for treating social anxiety disorder in adults: a Systematic review of studies published since 2015
  3. Temporal Precedence of Distress Tolerance in Predicting Anxiety and Depression: A Daily Diary Approach during Mindfulness-Based Intervention
  4. Acceptance and Commitment Therapy in Chronic Low Back Pain and Comorbid Depression: A Single-Case Study with Idiographic Network Analysis
  5. A Systematic Scoping Review of Fully Idiographic Network Analysis in Mental Health
  6. Efficacy and mechanisms of internet-delivered MBCT for adjustment disorder during the COVID-19 pandemic: A randomized controlled trial
  7. Evidence of Disrupted Hippocampal Gray‐ and White‐Matter Development in Adolescent Anxiety Disorders, Independent From Early‐Life Stress
  8. Research on translational psychological treatment: A comprehensive bibliometric analysis.
  9. PBAT Network Analysis: Spanish Validation and Cross-Cultural Perspectives
  10. Bipolar vs. unipolar scaling in dynamic network analyses of Ecological Momentary Assessment data
  11. The Psychometric Properties of the Interpersonal Emotion Regulation Questionnaire Among Chinese Caregivers of Children With Neurodevelopmental Disorders
  12. The risks versus the benefits of pharmacological intervention in social anxiety disorder in children
  13. Examining the Psychometric Network Structure of Social Anxiety: A Scoping Review
  14. Artificial Intelligence in Science and Society: The Vision of USERN
  15. Going beyond trauma: A scoping review on the prevalence of symptom-relevant negative autobiographical memories in anxiety disorders and obsessive-compulsive disorder.
  16. Individual differences in functional connectivity during suppression of imagined threat
  17. Targeting perfectionism in social anxiety with social mishap exposures.
  18. Study Protocol TransTAM: Transdiagnostic Research into Emotional Disorders and Cognitive-Behavioral Therapy of the Adaptive Mind
  19. Relationship between outcomes and processes in patients with chronic low back pain plus depressive symptoms: Idiographic analyses within a randomized controlled trial
  20. Development and validation of the Spanish Process-Based Assessment Tool (PBAT)
  21. Mindfulness as a therapeutic option for obsessive-compulsive disorder
  22. Going Beyond Trauma: A Scoping Review on the Prevalence of Symptom-Relevant Negative Autobiographical Memories in Anxiety Disorders and Obsessive-Compulsive Disorder
  23. Comment on Lundh (2023)
  24. Recurrent Negative Autobiographical Memories and Mental Health
  25. Neural Correlates of Suppressing and Imagining Future Threat
  26. A process-based approach to transtheoretical clinical research and training
  27. The Efficacy of Personalized Psychological Interventions in Adolescents: A Systematic Review and Meta-Analysis
  28. Process-based therapy as a novel treatment approach and framework for classifying psychopathology
  29. How a Process-Based Idionomic Approach Changes our Understanding of Mindfulness as a Method and Process
  30. The Relationship Between Psychological Inflexibility and Well-Being in Adults: A Meta-Analysis of the Acceptance and Action Questionnaire
  31. Do we need a novel framework for classifying psychopathology? A discussion paper
  32. Novel Approaches towards Studying Change: Implications for Understanding and Treating Psychopathology
  33. The Idionomic Future of Cognitive Behavioral Therapy: What Stands Out From Criticisms of ACT Development
  34. Prozessbasierter Ansatz in der Psychotherapie
  35. A biphasic relational approach to the evolution of human consciousness
  36. Distress tolerance as a mechanism of mindfulness for depression and anxiety: Cross-sectional and diary evidence
  37. Adaptation of the Interpersonal Emotion Regulation Questionnaire (IERQ) to Spanish in a Sample of Uruguayan University Students
  38. Comparing Kundalini Yoga, cognitive behavioral therapy, and stress education for generalized anxiety disorder: Anxiety and depression symptom outcomes
  39. Formalizing psychological interventions through network control theory
  40. Effect of cognitive behavioural therapy and yoga for generalised anxiety disorder on sleep quality in a randomised controlled trial: the role of worry, mindfulness, and perceived stress as mediators
  41. Major problems in clinical psychological science and how to address them. Introducing the DYNAMIC approach.
  42. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT
  43. The Compassion Balance: Understanding the Interrelation of Self- and Other-Compassion for Optimal Well-being
  44. The role of experiential avoidance in the early stages of an online mindfulness-based intervention: Two mediation studies
  45. Bistability and affect shift dynamics in the prediction of psychological well-being
  46. The Efficacy Of A Compassion, Acceptance And Mindfulness-based Pilot Intervention For Adolescents’ Test Anxiety: A Case Study Using The Academic Program
  47. Effect of psychotherapy for adult depression on self-esteem: A systematic review and meta-analysis
  48. A Systematic Evaluation of Machine Learning-based Biomarkers for Major Depressive Disorder across Modalities
  49. A Randomized Controlled Trial of an Online Self-Help Mindfulness Intervention for Emotional Distress: Serial Mediating Effects of Mindfulness and Experiential Avoidance
  50. Mindfulness-based interventions for anxiety and depression
  51. A personalised-approach to identifying important determinants of well-being
  52. A generative adversarial model of intrusive imagery in the human brain
  53. Enhanced Mental Reinstatement of Exposure to Improve Extinction Generalization: A Study on Claustrophobia and MRI Fear
  54. Process-based therapy: A personalized approach to treatment
  55. Distress Tolerance as a Mechanism of Mindfulness for Depression and Anxiety: Cross-Sectional and Diary Evidence
  56. The Compassion Balance: Understanding the Interrelation of Self- and Other-Compassion for Optimal Well-being
  57. Efficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Meta-Analysis of Recent Literature
  58. Formalizing psychological interventions through network control theory
  59. A process-based approach to cognitive behavioral therapy: A theory-based case illustration
  60. Temporal and contemporaneous network structures of affect and physical activity in emotional disorders
  61. A complex systems model of temporal fluctuations in depressive symptomatology
  62. Evolving an idionomic approach to processes of change: Towards a unified personalized science of human improvement
  63. Impact of preference for yoga or cognitive behavioral therapy in patients with generalized anxiety disorder on treatment outcomes and engagement
  64. Interpersonal emotion regulation questionnaire: psychometric properties of the Italian version and associations with psychopathology
  65. Psychotherapeutic Interventions and Processes
  66. The potential mediating role of anxiety sensitivity in the impact of mindfulness training on anxiety and depression severity and impairment: A randomized controlled trial
  67. Toward empirical process-based case conceptualization: An idionomic network examination of the process-based assessment tool
  68. Effectiveness and mechanism of a 4-week online self-help mindfulness intervention among individuals with emotional distress during COVID-19 in China
  69. Connectivity Patterns Evoked by Fearful Faces Demonstrate Reduced Flexibility Across a Shared Dimension of Adolescent Anxiety and Depression
  70. International application of the “Multidimensional Intervention for Social Anxiety” (MISA) program: II. Treatment effectiveness for social anxiety-related problems
  71. Correction to Caballo et al. (2021)
  72. What is the common ground for modern psychotherapy? A discussion paper based on EACLIPT’s 1st webinar
  73. Toward a Unified Framework for Positive Psychology Interventions: Evidence-Based Processes of Change in Coaching, Prevention, and Training
  74. Reward-Related Neural Circuitry in Depressed and Anxious Adolescents: A Human Connectome Project
  75. Affective styles and their association with anxiety and depression in a Japanese clinical sample
  76. Putting the “mental” back in “mental disorders”: a perspective from research on fear and anxiety
  77. Developing an item pool to assess processes of change in psychological interventions: The Process-Based Assessment Tool (PBAT)
  78. A Process-Based Approach to Cognitive Behavioral Therapy
  79. Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality data
  80. International application of the “Multidimensional Intervention for Social Anxiety” (MISA) program: I. Treatment effectiveness in patients with social anxiety
  81. Therapist Interventions and Skills as Predictors of Dropout in Outpatient Psychotherapy
  82. Distinct and interacting impacts of trait anxiety and a state anxiety manipulation on attentional switching
  83. Assessing Processes of Change in Psychological Interventions: The Process-Based Assessment Tool (PBAT)
  84. Metta-Based Therapy for Chronic Depression: a Wait List Control Trial
  85. Defining and Measuring Tolerance of Uncontrollability
  86. “Third‐wave” cognitive and behavioral therapies and the emergence of a process‐based approach to intervention in psychiatry
  87. Psychometric properties of interpersonal emotion regulation questionnaire in nonclinical and clinical population in Iran
  88. When is it appropriate to treat children with social anxiety, pharmacologically?
  89. Using diffusion MRI data acquired with ultra-high gradients to improve tractography in routine-quality data
  90. Correction to: The Future of Cognitive Behavioral Therapy
  91. The influence of anxiety sensitivity on mindfulness
  92. When two hearts beat as one: Heart-rate synchrony in social anxiety disorder
  93. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder
  94. The Future of Cognitive Behavioral Therapy
  95. The Impact of COVID-19 on mental health
  96. Mental health and clinical psychological science in the time of COVID-19: Challenges, opportunities, and a call to action.
  97. Report of the ACBS Task Force on the strategies and tactics of contextual behavioral science research
  98. Reduced Social Connectedness and Compassion Toward Close Others in Patients With Chronic Depression Compared to a Non-clinical Sample
  99. Enhanced mental reinstatement of exposure to improve extinction generalization: A study on claustrophobia and MRI fear
  100. Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder
  101. I’m Not Feeling It: Momentary Experiential Avoidance and Social Anxiety Among Individuals With Social Anxiety Disorder
  102. 30 Jahre Zeitschrift <b><i>Verhaltenstherapie</i></b>: Die Verhaltenstherapie als Motor der Professionalisierung der Psychotherapie
  103. Assessing psychological flexibility in test situations: The Test Anxiety Acceptance and Action Questionnaire for Adolescents
  104. Engagement with smartphone-delivered behavioural activation interventions: a study of the MoodMission smartphone application
  105. A process-based approach to psychological diagnosis and treatment:The conceptual and treatment utility of an extended evolutionary meta model
  106. Anhedonia is central for the association between quality of life, metacognition, sleep, and affective symptoms in generalized anxiety disorder: A complex network analysis
  107. Functional Alterations in Cerebellar Functional Connectivity in Anxiety Disorders
  108. Clinical psychology is an applied evolutionary science
  109. Evaluating Non–Statistically Significant Results From Trials in Practice
  110. Process-based functional analysis can help behavioral science step up to novel challenges: COVID - 19 as an example
  111. ENIGMA‐anxietyworking group: Rationale for and organization oflarge‐scaleneuroimaging studies of anxiety disorders
  112. A Pilot Study of Cardiovascular Reactivity in Children With Autism Spectrum Disorder
  113. The Age of Depression and Its Treatments
  114. The Mediating Role of Non-reactivity to Mindfulness Training and Cognitive Flexibility: A Randomized Controlled Trial
  115. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder
  116. Loving-Kindness Meditation Promotes Mental Health in University Students
  117. Affective Styles in Panic Disorder and Specific Phobia: Changes Through Cognitive Behavior Therapy and Prediction of Remission
  118. Multimodal Brain Connectomics Predict Longitudinal Symptom Change in Adolescent Depression
  119. Resting State Connectivity Associated With Changes in Anxiety Symptoms in Adolescence Over One Year
  120. Treatments for internet addiction, sex addiction and compulsive buying: A meta-analysis
  121. Idionomic Links of Reappraisal and Emotion Suppression with Positive and Negative Affect in Daily Life: Group Means Often Fail to Apply to Individuals
  122. Idionomic Links of Reappraisal and Emotion Suppression with Positive and Negative Affect in Daily Life: Group Means Often Fail to Apply to Individuals
  123. Beyond linear mediation: Toward a dynamic network approach to study treatment processes
  124. Psychometrische Eigenschaften der deutschsprachigen Version des Interpersonal Emotion Regulation Questionnaire
  125. A randomized clinical trial of group and individual Cognitive-Behavioral Therapy approaches for Social Anxiety Disorder
  126. Biofeedback and Neurofeedback for Anxiety Disorders: A Quantitative and Qualitative Systematic Review
  127. Brain function and clinical characterization in the Boston adolescent neuroimaging of depression and anxiety study
  128. Image acquisition and quality assurance in the Boston Adolescent Neuroimaging of Depression and Anxiety study
  129. Emotion Regulation Flexibility in Generalized Anxiety Disorder
  130. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis
  131. The relationship between trait mindfulness and affective symptoms: A meta-analysis of the Five Facet Mindfulness Questionnaire (FFMQ)
  132. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder
  133. Current understanding of fear learning and memory in humans and animal models and the value of a linguistic approach for analyzing fear learning and memory in humans
  134. Integrating Metta Into CBT: How Loving Kindness and Compassion Meditation Can Enhance CBT for Treating Anxiety and Depression
  135. Therapeutic change processes link and clarify targets and outcomes
  136. Memory editing from science fiction to clinical practice
  137. From Extinction Learning to Anxiety Treatment: Mind the Gap
  138. Imagine there are no therapy brands, it isn’t hard to do
  139. The Effect of a Brief Mindfulness Training on Distress Tolerance and Stress Reactivity
  140. F31. Intrinsic Brain Network Implicated in the Behavioral Inhibition System of Adolescents With Depression/Anxiety
  141. Additional Approaches to Treatment of Depression
  142. Psychometric properties of the Liebowitz Social Anxiety Scale in a large cross-cultural Spanish and Portuguese speaking sample
  143. Psychometric Properties of the Turkish Version of the Interpersonal Emotion Regulation Questionnaire (IERQ)
  144. Network Dynamics of Positive and Negative Affect in Bipolar Disorder
  145. Effect of Acceptance Versus Attention on Pain Tolerance: Dissecting Two Components of Mindfulness
  146. Focusing on the Correct Level of Analysis in Process-Based Therapy
  147. Erfassung der Emotionsregulation bei Jugendlichen anhand des „Affective Style Questionnaire – Youth (ASQ-Y)“
  148. Global Mental Health and Psychotherapy
  149. Pharmacological Treatments for Disordered Gambling: A Meta-analysis
  150. Survival circuits and therapy: from automaticity to the conscious experience of fear and anxiety
  151. Effects of post-exposure naps on exposure therapy for social anxiety
  152. Facets of Mindfulness in Adults with Generalized Anxiety Disorder and Impact of Co-occurring Depression
  153. Functional Analysis Is Dead: Long Live Functional Analysis
  154. Differences in Compassion, Well-being, and Social Anxiety Between Japan and the USA
  155. Interpersonal Emotion Regulation: A Review of Social and Developmental Components
  156. The limitations of equivalence and non-inferiority trials
  157. The role of the individual in the coming era of process-based therapy
  158. Going meta on metacognitive interventions
  159. Trial-Based Cognitive Therapy: Efficacy of a New CBT Approach for Treating Social Anxiety Disorder with Comorbid Depression
  160. Use of Multiple Regulation Strategies in Spontaneous Emotion Regulation
  161. A psychological model of the use of psychological intervention science: Seven rules for making a difference
  162. A complex network approach to clinical science
  163. Supported internet-delivered cognitive behavior therapy programs for depression, anxiety, and stress in university students: Feasibility, acceptability, effectiveness, and satisfaction (Preprint)
  164. Supported internet-delivered cognitive behavior therapy programs for depression, anxiety, and stress in university students: Open feasibility trial of acceptability, effectiveness, and satisfaction (Preprint)
  165. Loving Kindness Meditation zur Behandlung der chronischen Depression
  166. Motivation to Participate in PTSD Research
  167. Affective Styles in Mood and Anxiety Disorders – Clinical Validation of the “Affective Style Questionnaire” (ASQ)
  168. Socratic Dialogue and Guided Discovery in Cognitive Behavioral Therapy: A Modified Delphi Panel
  169. The Future of Intervention Science: Process-Based Therapy
  170. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review
  171. Using network analysis for the prediction of treatment dropout in patients with mood and anxiety disorders: A methodological proof-of-concept study
  172. The Processes of Cognitive Behavioral Therapy: A Review of Meta-Analyses
  173. Removal notice to Effect of Intranasal Oxytocin Administration on Psychiatric Symptoms: A Meta-Analysis of Placebo-Controlled Studies Psychiatr Res. 228 (2015) 708-714
  174. Kundalini Yoga for Generalized Anxiety Disorder: An Exploration of Treatment Efficacy and Possible Mechanisms
  175. Rethinking Avoidance: Toward a Balanced Approach to Avoidance in Treating Anxiety Disorders
  176. Kognition und Emotion
  177. The Evidence for Cognitive Behavioral Therapy
  178. Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials
  179. Some problems with non-inferiority tests in psychotherapy research: psychodynamic therapies as an example
  180. The subjective experience of emotion: a fearful view
  181. Why Cognitive Behavioral Therapy Is the Current Gold Standard of Psychotherapy
  182. Linguistic analysis of patients with mood and anxiety disorders during cognitive behavioral therapy
  183. Correction to: Differential Treatment Mechanisms in Mindfulness Meditation and Progressive Muscle Relaxation
  184. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction?
  185. Modern CBT: Moving Toward Process-Based Therapies
  186. Longitudinal Network Stability of the Functional Impairment of Anxiety and Depression
  187. Characterizing Social Anxiety Disorder
  188. Maintenance and Follow-Up Strategies
  189. Overall Description of Treatment Strategy
  190. Research Basis for the Treatment Model
  191. Session-by-Session Outline
  192. Differential Treatment Mechanisms in Mindfulness Meditation and Progressive Muscle Relaxation
  193. Processes of change after a sudden gain and relation to treatment outcome—Evidence for an upward spiral.
  194. Mindfulness-Based Interventions for Anxiety and Depression
  195. The Evolution of Cognitive Behavioral Therapy for Anxiety and Depression
  196. The third wave of cognitive behavioral therapy and the rise of process‐based care
  197. Working hard for oneself or others: Effects of oxytocin on reward motivation in social anxiety disorder
  198. Efficacy of face-to-face versus self-guided treatments for disordered gambling: A meta-analysis
  199. The effect of heart rate variability biofeedback training on stress and anxiety: a meta-analysis
  200. Impact of Cognitive Reappraisal on Negative Affect, Heart Rate, and Intrusive Memories in Traumatized Refugees
  201. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders
  202. 990. Effects of Post-Exposure Naps and Home Sleep on Exposure Therapy for Social Anxiety
  203. 1119 ASSOCIATIONS OF NEO-PI-R PERSONALITY DOMAINS WITH SLEEP QUALITY, CHRONOTYPE, AND OUTCOMES IN EXPOSURE THERAPY FOR SOCIAL ANXIETY DISORDER
  204. 1120 EFFECTS OF POST-EXPOSURE NAPS ON CHANGE IN AUTONOMIC AROUSAL TO A SOCIAL CHALLENGE ACROSS EXPOSURE THERAPY FOR SOCIAL ANXIETY
  205. Effect of treatments for depression on quality of life: a meta-analysis
  206. The conditional process model of mindfulness and emotion regulation: An empirical test
  207. Corrigendum to “The effect of psychotherapeutic interventions on positive and negative affect in depression: A systematic review and meta-analysis” [J. Affect. Disord. 202 (2016) 153–162]
  208. Initial severity of depression and efficacy of cognitive–behavioural therapy: Individual-participant data meta-analysis of pill-placebo-controlled trials
  209. A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators
  210. International Perspectives on Psychotherapy
  211. Internet-Delivered Treatment for Depression, Anxiety, and Stress in University Students: A Patient Preference Trial
  212. Self-relevant threat contexts enhance early processing of fear-conditioned faces
  213. Psychometric properties of the Chinese version of the Affective Style Questionnaire and its role as a moderator of the relationship between stress and negative affect
  214. A Complex Network Perspective on Clinical Science
  215. Quantity and Quality of Homework Compliance: A Meta-Analysis of Relations With Outcome in Cognitive Behavior Therapy
  216. The effect of psychotherapeutic interventions on positive and negative affect in depression: A systematic review and meta-analysis
  217. A Complex Network Perspective on Clinical Science
  218. A Complex Network Perspective on Clinical Science
  219. Effect of Hatha yoga on anxiety: a meta-analysis
  220. Schrödinger’s Cat andd-Cycloserine to Augment Exposure Therapy—Both Are Alive and Dead
  221. Emotional suppression in torture survivors: Relationship to posttraumatic stress symptoms and trauma-related negative affect
  222. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions
  223. Effect of regulating anger and sadness on decision-making
  224. Self-compassion enhances the efficacy of explicit cognitive reappraisal as an emotion regulation strategy in individuals with major depressive disorder
  225. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER
  226. Acceptability and proof of concept of internet-delivered treatment for depression, anxiety, and stress in university students: protocol for an open feasibility trial
  227. The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder
  228. New Frontiers in Cognitive Behavioral Therapies: Introduction
  229. Training children’s theory-of-mind: A meta-analysis of controlled studies
  230. Examining the efficacy of d -cycloserine to augment therapeutic learning in depression
  231. The Effects of Mindfulness Training on Emotional Health in Chinese Long-Term Male Prison Inmates
  232. Psychodynamic therapy: a poorly defined concept with questionable evidence
  233. Interpersonal Emotion Regulation Questionnaire (IERQ): Scale Development and Psychometric Characteristics
  234. Episodic future thinking in generalized anxiety disorder
  235. Effects of compassionate thinking on negative emotions
  236. Children's emotion understanding: A meta-analysis of training studies
  237. Psychometric properties of an innovative self-report measure: The Social Anxiety Questionnaire for adults.
  238. Yoga for generalized anxiety disorder: design of a randomized controlled clinical trial
  239. Brain connectomics predict response to treatment in social anxiety disorder
  240. RETRACTED: Effect of intranasal oxytocin administration on psychiatric symptoms: A meta-analysis of placebo-controlled studies
  241. Attention allocation in social anxiety during a speech
  242. Neuroenhancement of Exposure Therapy in Anxiety Disorders
  243. Dose timing of d-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale
  244. Altered Resting-State Functional Connectivity of the Frontal-Striatal Reward System in Social Anxiety Disorder
  245. D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach
  246. Treatments for Social Anxiety Disorder: Considerations Regarding Psychodynamic Therapy Findings
  247. The structure of feared social situations among race-ethnic minorities and Whites with social anxiety disorder in the United States
  248. Reservations about the Conclusions of the Interdivisional (APA Divisions 12 & 29) Task Force on Evidence-Based Therapy Relationships: What Do We Know, What Don't We Know?
  249. Enhanced association between perceptual stimuli and trauma-related information in individuals with posttraumatic stress disorder symptoms
  250. Cognitions as mediators in the relationship between self-compassion and affect
  251. The Potential Contribution of the Cognitive-Behavioral Model for the Classification of Emotional Disorders
  252. The Future of Cognitive Behavioral Therapy
  253. Loving-Kindness Meditation to Target Affect in Mood Disorders: A Proof-of-Concept Study
  254. Differences Between People Who Use Only Facebook and Those Who Use Facebook Plus Twitter
  255. "Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: A meta-analysis": Correction to Hofmann, Wu, and Boettcher (2014).
  256. d-Cycloserine Augmentation of Cognitive Behavioral Therapy for Anxiety Disorders: an Update
  257. Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis
  258. Advances in data analytic methods for evaluating treatment outcome and mechanisms of change: Introduction to the special issue.
  259. Culture and affect: the factor structure of the affective style questionnaire and its relation with depression and anxiety among Japanese
  260. Differences in social anxiety between men and women across 18 countries
  261. Self-compassion as an emotion regulation strategy in major depressive disorder
  262. Toward a Cognitive-Behavioral Classification System for Mental Disorders
  263. Cognitive-Behavioral Therapy: Next Generation of Treatments
  264. Emotion regulation predicts symptoms of depression over five years
  265. Yohimbine Enhancement of Exposure Therapy for Social Anxiety Disorder: A Randomized Controlled Trial
  266. Interpersonal Emotion Regulation Model of Mood and Anxiety Disorders
  267. Yoga‐Enhanced Cognitive Behavioural Therapy (Y‐CBT) for Anxiety Management: A Pilot Study
  268. Cross-Cultural Aspects of Anxiety Disorders
  269. Attachment Style Moderates the Effects of Oxytocin on Social Behaviors and Cognitions During Social Rejection
  270. Attention Bias Modification Training Via Smartphone to Reduce Social Anxiety: A Randomized, Controlled Multi-Session Experiment
  271. Sudden gains in internet-based cognitive behaviour therapy for severe health anxiety
  272. The benefits of being mindful: Trait mindfulness predicts less stress reactivity to suppression
  273. Hyper-Connectivity of Subcortical Resting-State Networks in Social Anxiety Disorder
  274. d-CYCLOSERINE FOR TREATING ANXIETY DISORDERS: MAKING GOOD EXPOSURES BETTER AND BAD EXPOSURES WORSE
  275. Moderation and mediation of the effect of attention training in social anxiety disorder
  276. Erratum to: The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
  277. SOCIAL ANXIETY DISORDER IN DSM-5
  278. Body image in social anxiety disorder, obsessive–compulsive disorder, and panic disorder
  279. Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: A meta-analysis.
  280. Evidence-based psychological interventions and the common factors approach: The beginnings of a rapprochement?
  281. Patterns of early change and their relationship to outcome and early treatment termination in patients with panic disorder.
  282. Cognitive enhancers for the treatment of anxiety disorders
  283. Front matter
  284. Social Anxiety
  285. The need for a behavioural science focus in research on mental health and mental disorders
  286. Advancing psychotherapy and evidence-based psychological interventions
  287. The Effects of Approach–Avoidance Modification on Social Anxiety Disorder: A Pilot Study
  288. Bridging the Theory-Practice Gap by Getting Even Bolder With the Boulder Model
  289. Development of a Brief Version of the Social Phobia Inventory Using Item Response Theory: The Mini-SPIN-R
  290. GLUCOCORTICOIDS ENHANCE IN VIVO EXPOSURE-BASED THERAPY OF SPIDER PHOBIA
  291. Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis
  292. EMOTION REGULATION PREDICTS ANXIETY OVER A FIVE-YEAR INTERVAL: A CROSS-LAGGED PANEL ANALYSIS
  293. d-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions
  294. Psychological treatment of social anxiety disorder improves body dysmorphic concerns
  295. Relationship between social anxiety and perceived trustworthiness
  296. SLEEP QUALITY PREDICTS TREATMENT OUTCOME IN CBT FOR SOCIAL ANXIETY DISORDER
  297. Mindfulness-based therapy: A comprehensive meta-analysis
  298. d -Cycloserine as an Augmentation Strategy With Cognitive-Behavioral Therapy for Social Anxiety Disorder
  299. Loving-Kindness in the Treatment of Traumatized Refugees and Minority Groups: A Typology of Mindfulness and the Nodal Network Model of Affect and Affect Regulation
  300. D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
  301. D-Cycloserine Enhancement of Fear Extinction is Specific to Successful Exposure Sessions: Evidence from the Treatment of Height Phobia
  302. The Science of Cognitive Therapy
  303. What Is the Typical Response to Sexual Assault? Reply to Bonanno (2013)
  304. The Art and Science of Psychotherapy
  305. Social Mishap Exposures for Social Anxiety Disorder: An Important Treatment Ingredient
  306. Effect of Suppression, Reappraisal, and Acceptance of Emotional Pictures on Acoustic Eye-Blink Startle Magnitude
  307. The relationship of PTSD to key somatic complaints and cultural syndromes among Cambodian refugees attending a psychiatric clinic: The Cambodian Somatic Symptom and Syndrome Inventory (CSSI)
  308. CBT for Anxiety Disorders
  309. Comparison of psychotherapies for adult depression to pill placebo control groups: a meta-analysis
  310. Social Anxiety Disorder: Treatment Targets and Strategies
  311. EVALUATION OF THE PROPOSED SOCIAL ANXIETY DISORDER SPECIFIER CHANGE FOR DSM-5 IN A TREATMENT-SEEKING SAMPLE OF ANXIOUS YOUTH
  312. The Pursuit of Happiness and Its Relationship to the Meta-experience of Emotions and Culture
  313. Acceptance and Mindfulness Techniques as Applied to Refugee and Ethnic Minority Populations With PTSD: Examples From "Culturally Adapted CBT"
  314. Augmentation of exposure therapy with post-session administration of d-cycloserine
  315. Can fMRI be used to predict the course of treatment for social anxiety disorder?
  316. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: Prognostic and prescriptive variables.
  317. Distinguishing integrative from eclectic practice in cognitive behavioral therapies.
  318. Emotion Regulation Skills Training Enhances the Efficacy of Inpatient Cognitive Behavioral Therapy for Major Depressive Disorder: A Randomized Controlled Trial
  319. Predicting Treatment Response in Social Anxiety Disorder From Functional Magnetic Resonance Imaging
  320. Sudden gains in cognitive therapy and interpersonal therapy for social anxiety disorder.
  321. The impacts of parental loss and adverse parenting on mental health: Findings from the National Comorbidity Survey-Replication.
  322. Assessment of Social and Generalized Anxiety Disorder
  323. Efficacy of Attention Bias Modification Using Threat and Appetitive Stimuli: A Meta-Analytic Review
  324. The Effect ofd-Cycloserine on Subliminal Cue Exposure in Spider Fearful Individuals
  325. Psychological interventions for fear of blushing
  326. THE ROLE OF ATTRIBUTION OF TRAUMA RESPONSIBILITY IN POSTTRAUMATIC STRESS DISORDER FOLLOWING MOTOR VEHICLE ACCIDENTS
  327. D-Cycloserine as an Augmentation Strategy for Cognitive Behavioral Therapy for Anxiety Disorders: An Update
  328. GENERALIZED ANXIETY DISORDER AND THE PROPOSED ASSOCIATED SYMPTOMS CRITERION CHANGE FOR DSM-5 IN A TREATMENT-SEEKING SAMPLE OF ANXIOUS YOUTH
  329. A randomized placebo-controlled trial of d-cycloserine and exposure therapy for posttraumatic stress disorder
  330. A Yoga Intervention for Music Performance Anxiety in Conservatory Students
  331. The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
  332. Trajectories of PTSD symptoms following sexual assault: Is resilience the modal outcome?
  333. The Future of Cognitive Therapy and Research is Bright and Clear
  334. Internet-delivered attention bias modification training in individuals with social anxiety disorder - a double blind randomized controlled trial
  335. Admixture analysis of the diagnostic subtypes of social anxiety disorder: Implications for the DSM-V
  336. FIVE SESSIONS AND COUNTING: CONSIDERING ULTRA-BRIEF TREATMENT FOR PANIC DISORDER
  337. Linguistic correlates of social anxiety disorder
  338. The Multidimensional Nature and Multicultural Validity of a New Measure of Social Anxiety: The Social Anxiety Questionnaire for Adults
  339. The natural course of social anxiety disorder among adolescents and young adults
  340. Effects of emotion regulation strategies on smoking craving, attentional bias, and task persistence
  341. The relationship between childhood exposure to trauma and intermittent explosive disorder
  342. Der „Affective Style Questionnaire (ASQ)”: Deutsche Adaption und Validitäten
  343. Adapting CBT for traumatized refugees and ethnic minority patients: Examples from culturally adapted CBT (CA-CBT)
  344. Functional impairment in social anxiety disorder
  345. A Roadmap for the Research and Practice of Combination Strategies
  346. Psychobiological Approaches for Anxiety Disorders
  347. EMOTION DYSREGULATION MODEL OF MOOD AND ANXIETY DISORDERS
  348. Mindfulness and Acceptance: The Perspective of Cognitive Therapy
  349. Evaluation of the Glycine Transporter Inhibitor Org 25935 as Augmentation to Cognitive-Behavioral Therapy for Panic Disorder
  350. Neurobiological correlates of cognitions in fear and anxiety: A cognitive–neurobiological information-processing model
  351. Why do people use Facebook?
  352. Collaboration in Multicultural Therapy: Establishing a Strong Therapeutic Alliance Across Cultural Lines
  353. Does fear reactivity during exposure predict panic symptom reduction?
  354. Perception of racial discrimination and psychopathology across three U.S. ethnic minority groups.
  355. Sudden gains during psychological treatments of anxiety and depression: A meta-analysis.
  356. Accidental and Intentional Perpetration of Serious Injury or Death: Correlates and Relationship to Trauma Exposure
  357. Treatment change of somatic symptoms and cultural syndromes among Cambodian refugees with PTSD
  358. Loving-kindness and compassion meditation: Potential for psychological interventions
  359. Differences between early and late drop-outs from treatment for obsessive–compulsive disorder
  360. Rejection sensitivity mediates the relationship between social anxiety and body dysmorphic concerns
  361. Perceived Impact of Socially Anxious Behaviors on Individuals' Lives in Western and East Asian Countries
  362. Effects ofd-Cycloserine on Craving to Alcohol Cues in Problem Drinkers: Preliminary Findings
  363. Cognitive enhancers for anxiety disorders
  364. Cognitive enhancers for the treatment of neuropsychiatric disorders: Clinical and preclinical investigations
  365. Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness
  366. The factor structure of the Social Interaction Anxiety Scale and the Social Phobia Scale
  367. Long-Term Outcomes of War-Related Death of Family Members in Kosovar Civilian War Survivors
  368. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: A pilot study comparing CA-CBT to applied muscle relaxation
  369. Response to the Letter to the Editor by J.H. McAuley et al.
  370. The effect of emotion regulation strategies on anger
  371. Deficits in emotion-regulation skills predict alcohol use during and after cognitive–behavioral therapy for alcohol dependence.
  372. Emotional granularity and borderline personality disorder.
  373. Some more fundamental problems in clinical research: Comment on “Statistical significance testing and clinical trials”.
  374. Adopting Guidelines into Clinical Practice: Implementation of Trastuzumab in the Adjuvant Treatment of Breast Cancer in Lower Saxony, Germany, in 2007
  375. Complicating Factors
  376. Cultural aspects in social anxiety and social anxiety disorder
  377. Recent advances in the psychosocial treatment of social anxiety disorder
  378. Relationship between social anxiety disorder and body dysmorphic disorder
  379. Social anxiety and social norms in individualistic and collectivistic countries
  380. Psychological treatments for fibromyalgia: A meta-analysis
  381. Cognitive-behavioral Therapy with Adults
  382. Emotional response patterns during social threat in individuals with generalized social anxiety disorder and non-anxious controls
  383. Psychophysiological correlates of generalized anxiety disorder with or without comorbid depression
  384. Catastrophic Appraisal and Perceived Control as Moderators of Treatment Response in Panic Disorder
  385. The Empirical Status of the “New Wave” of Cognitive Behavioral Therapy
  386. Posttraumatic stress and social anxiety: the interaction of traumatic events and interpersonal fears
  387. A Cross-Ethnic Comparison of Lifetime Prevalence Rates of Anxiety Disorders
  388. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: A meta-analysis
  389. Review: mindfulness-based therapies effective for anxiety and depression
  390. The type IV phosphodiesterase inhibitor rolipram disturbs expression and extinction of conditioned fear in mice
  391. Can a one-weekend group therapy reduce fear of blushing? Results of an open trial
  392. Effect of affect on social cost bias in social anxiety disorder
  393. Editorial
  394. Temporal and structural dynamics of anxiety sensitivity in predicting fearful responding to a 35% CO2 challenge
  395. The serotonin transporter gene and risk for alcohol dependence: A meta-analytic review
  396. Culture and the anxiety disorders: recommendations for DSM-V
  397. Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
  398. Panic disorder: a review of DSM-IV panic disorder and proposals for DSM-V
  399. Book review
  400. Measuring Social Anxiety in 11 Countries
  401. The Spanish Version of the Self-Statements During Public Speaking Scale
  402. Avoiding Treatment Failures in the Anxiety Disorders
  403. A psychobiocultural model of orthostatic panic among Cambodian refugees: Flashbacks, catastrophic cognitions, and reduced orthostatic blood-pressure response.
  404. Introduction: Toward an Understanding of Social Anxiety Disorder
  405. Respiratory and cognitive mediators of treatment change in panic disorder: Evidence for intervention specificity.
  406. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review.
  407. Evolution of Terminology and Constructs in Social Anxiety and its Disorders
  408. Genetic Basis of Social Anxiety Disorder
  409. Mechanisms of Action in the Treatment of Social Anxiety Disorder
  410. Neuroendocrinology and Neuroimaging Studies of Social Anxiety Disorder
  411. Psychopharmacology for Social Anxiety Disorder
  412. Relation to Clinical Syndromes in Adulthood
  413. Social Anxiety
  414. Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials
  415. Meta-analysis of the placebo response in antidepressant trials
  416. Schlusswort: Wie müsste eine aussagekräftige Metaanalyse zur psychodynamischen Langzeittherapie gestaltet sein?
  417. Avoiding Treatment Failures in Social Anxiety Disorder
  418. Avoiding Treatment Failures in Specific Phobias
  419. Introduction
  420. Resolving Treatment Complications Associated with Comorbid Anxiety and Substance Use Disorders
  421. Book review
  422. Anxiety Disorder Presentations in Asian Populations: A Review
  423. Mechanisms of Efficacy of CBT for Cambodian Refugees with PTSD: Improvement in Emotion Regulation and Orthostatic Blood Pressure Response
  424. Panic Disorder, Panic Attacks and Panic Attack Symptoms across Race-Ethnic Groups: Results of the Collaborative Psychiatric Epidemiology Studies
  425. When social anxiety disorder co-exists with risk-prone, approach behavior: Investigating a neglected, meaningful subset of people in the National Comorbidity Survey-Replication
  426. The Affective Style Questionnaire: Development and Psychometric Properties
  427. The Upside of Being Socially Anxious: Psychopathic Attributes and Social Anxiety are Negatively Associated
  428. Is it Beneficial to Add Pharmacotherapy to Cognitive-Behavioral Therapy When Treating Anxiety Disorders? A Meta-Analytic Review
  429. Anxiety disorders moderate the association between externalizing problems and substance use disorders: Data from the National Comorbidity Survey-Revised
  430. How to handle anxiety: The effects of reappraisal, acceptance, and suppression strategies on anxious arousal
  431. Die Psychoanalyse soll gerettet werden
  432. Changes in respiration mediate changes in fear of bodily sensations in panic disorder
  433. Processing of facial affect under social threat in socially anxious adults: mood matters
  434. Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale
  435. Effects of D-Cycloserine Administration on Weekly Nonemotional Memory Tasks in Healthy Participants
  436. Electrophysiological evidence of attentional biases in social anxiety disorder
  437. Acceptance and Commitment Therapy: New Wave or Morita Therapy?
  438. Pitfalls of Meta-Analyses
  439. The Power of Expectation – Understanding the Placebo and Nocebo Phenomenon
  440. The Panic Attack–Posttraumatic Stress Disorder Model: Applicability to Orthostatic Panic Among Cambodian Refugees
  441. Single Case Evaluation of an Intensive Cognitive Behavioral Treatment for Generalized Social Anxiety Disorder
  442. New Frontiers in Psychological Interventions for Social Anxiety Disorder
  443. A meta-analytic review of the effects of psychotherapy control conditions for anxiety disorders
  444. Cognitive Behavioral Therapy for Social Anxiety Disorder
  445. Cognitive-Behavioral Therapy for Adult Anxiety Disorders
  446. Negative self-focused cognitions mediate the effect of trait social anxiety on state anxiety
  447. Cognitive processes during fear acquisition and extinction in animals and humans: Implications for exposure therapy of anxiety disorders
  448. The Missing Data Problem in Meta-analyses
  449. Acceptance and mindfulness-based therapy: New wave or old hat?
  450. Common misconceptions about cognitive mediation of treatment change: A commentary to Longmore and Worrell (2007)
  451. Electrophysiological correlates of spatial orienting towards angry faces: A source localization study
  452. The high-novelty–seeking, impulsive subtype of generalized social anxiety disorder
  453. Cognitive Factors that Maintain Social Anxiety Disorder: a Comprehensive Model and its Treatment Implications
  454. Treating Avoidant Personality Disorder: The Case of Paul
  455. Enhancing exposure-based therapy from a translational research perspective
  456. Dizziness- and Palpitations-predominant Orthostatic Panic: Physiology, Flashbacks, and Catastrophic Cognitions
  457. When ambiguity hurts: Social standards moderate self-appraisals in generalized social phobia
  458. Trait affect moderates cortical activation in response to state affect
  459. Influence of expressed emotion and perceived criticism on cognitive-behavioral therapy for social phobia
  460. Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder.
  461. Sensory-processing sensitivity in social anxiety disorder: Relationship to harm avoidance and diagnostic subtypes
  462. The Driving Cognitions Questionnaire: Development and preliminary psychometric properties
  463. Clinical Perspectives on the Combination of D-Cycloserine and Cognitive-Behavioral Therapy for the Treatment of Anxiety Disorders
  464. The Importance of Culture in Cognitive and Behavioral Practice
  465. Augmentation Treatment of Psychotherapy for Anxiety Disorders with D-Cycloserine
  466. Effects of suppression and acceptance on emotional responses of individuals with anxiety and mood disorders
  467. Panic attack symptom dimensions and their relationship to illness characteristics in panic disorder
  468. Autonomic correlates of social anxiety and embarrassment in shy and non-shy individuals
  469. Cultural differences in perceived social norms and social anxiety
  470. Full Steam Ahead: An Editorial Update
  471. The emotional consequences of social pragmatism: The psychophysiological correlates of self-monitoring
  472. Sex differences in face recognition and influence of facial affect
  473. Anxiety goes under the skin: Behavioral inhibition, anxiety, and autonomic arousal in speech-anxious males
  474. Cardiovascular Arousal in Individuals With Autism
  475. The Tridimensional Personality Questionnaire: Changes during psychological treatment of social phobia
  476. Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
  477. Recent Advances in the Treatment of Social Phobia: Introduction to the Special Issue
  478. Social Self-Reappraisal Therapy for Social Phobia: Preliminary Findings
  479. A taxometric investigation of the latent structure of social anxiety disorder in outpatients with anxiety and mood disorders
  480. Acceptability and suppression of negative emotion in anxiety and mood disorders.
  481. Sudden gains during therapy of social phobia.
  482. Tinnitus among Cambodian refugees: Relationship to PTSD severity
  483. Treatment attrition during group therapy for social phobia
  484. The growing up of Cognitive and Behavioral Practice
  485. Assessing Cardiovascular Responses to Stressors in Individuals With Autism Spectrum Disorders
  486. Perception of control over anxiety mediates the relation between catastrophic thinking and social anxiety in social phobia
  487. Cognitive Assessment of Social Anxiety: a Comparison of Self‐report and Thought Listing Methods
  488. Is CBT already the Dominant Paradigm in Psychotherapy Research and Practice?
  489. Comorbid PTSD and Social Phobia in a Treatment-Seeking Population
  490. The impact of self-construals on social anxiety: a gender-specific interaction
  491. A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: A cross-over design
  492. Mediation of changes in anxiety and depression during treatment of social phobia.
  493. The Worried Mind: Autonomic and Prefrontal Activation During Worrying.
  494. The nature and expression of social phobia: Toward a new classification
  495. Cognitive behaviour therapy in full flight
  496. Non‐specific encoding of threat in social phobia and panic disorder
  497. State Personality Disorder in Social Phobia
  498. Coping and anxiety in college students after the September 11thterrorist attacks
  499. Pitfalls of Meta-Analyses
  500. Encoding processes in social anxiety*1
  501. Encoding processes in social anxiety
  502. A self-applied, Internet-based intervention for fear of public speaking
  503. Changes in Self-Perception During Treatment of Social Phobia.
  504. Cognitive Mediation of Treatment Change in Social Phobia.
  505. Cognitive Mediation of Treatment Change in Social Phobia.
  506. Scoring error of social avoidance and distress scale and its psychometric implications
  507. Review: cognitive behavioural interventions may be effective for chronic fatigue syndrome and chronic back pain
  508. Social anxiety, depression, and PTSD in Vietnam veterans
  509. To Believe or Not to Believe: Cognitive and Psychodynamic Approaches to Delusional Disorder
  510. Evolutionary Mechanisms of Fear and Anxiety
  511. CLINICAL FEATURES OF FOUR DSM-IV–SPECIFIC PHOBIA SUBTYPES
  512. The Liebowitz social anxiety scale as a self-report instrument: a preliminary psychometric analysis
  513. Disentangling self-descriptions and self-evaluations under conditions of high self-focused attention: effects of mirror exposure
  514. Fisher's fallacy and NHST's flawed logic.
  515. Fisher's fallacy and NHST's flawed logic.
  516. More science, not less.
  517. More science, not less.
  518. Grief, Psychosis, and Panic Intervention with a Psychotic Patient: Integrating Psychodynamic and Cognitive-Behavioral Approaches
  519. Cognitive-behavioral treatment for social phobia in Parkinson's disease: A single-case study
  520. Information processing in social phobia: a critical review
  521. Potentially traumatizing events in panic disorder and other anxiety disorders
  522. Self-focused attention before and after treatment of social phobia
  523. The Anxiety Disorders.
  524. Treatment of Social Phobia: Potential Mediators and Moderators
  525. An instrument to assess self-statements during public speaking: Scale development and preliminary psychometric properties
  526. Cognitive-Behavioral Treatment of Panic in Patients With Schizophrenia: Preliminary Findings
  527. Treatment of social phobia: Potential mediators and moderators.
  528. Modifying CBT to treat panic disorder in patients with schizophrenia
  529. Why Do Personality Disorders Change? Possible Explanations From Cognitive and Psychodynamic Models
  530. Panic provocation procedures in the treatment of panic disorder: Early perspectives and case studies
  531. Relationship between panic and schizophrenia
  532. Subtypes of social phobia in adolescents
  533. Introducing the grandmother test into psychological science.
  534. Of treatments and technologies
  535. The value of psychophysiological data for cognitive behavioral treatment of panic disorder
  536. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder
  537. Effects of panic disorder treatments on personality disorder characteristics
  538. Defining empirically supported therapies.
  539. Pretreatment Attrition in a Comparative Treatment Outcome Study on Panic Disorder
  540. Speech disturbances and gaze behavior during public speaking in subtypes of social phobia
  541. How specific are specific phobias?
  542. Randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a new isoindoline derivative (DN-2327) in generalized anxiety
  543. A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease
  544. Ambulatory psychophysiological monitoring: A potentially useful tool when treating panic relapse
  545. Activation in novice and expert parachutists while jumping
  546. Issues related to social anxiety among controls in social phobia research
  547. Psychotherapy for panic disorder
  548. Social phobia with and without avoidant personality disorder: Preliminary behavior therapy outcome findings
  549. Conditioning theory: a model for the etiology of public speaking anxiety?
  550. Psychophysiological differences between subgroups of social phobia.
  551. Clinical characteristics of driving phobia
  552. Does behavioral treatment of social phobia lead to cognitive changes?
  553. Introduction by Stefan G. Hofmann and Mark A. Reinecke